Jakob Lindberg


Jakob Lindberg was appointed as CSO in 2020.

In addition to being CSO of Oncopeptides, Jakob is a Venture Partner at Patricia Industries, a part of Investor AB.

Jakob was CEO of Oncopetides AB between 2011 and 2020. His previous roles include being an analyst at Merrill Lynch & Co and a consultant at McKinsey & Co. Jakob was co-founder of Cell...

Roles at Oncopeptides AB

  • CSO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.